EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte Studie

Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Anna Martling iD, Ida Hed Myrberg, Mef Nilbert, Henrik Grönberg, Fredrik Granath, Martin Eklund, Tom Öresland, Lene H Iversen, Carola Haapamäki, Martin Janson, Karin Westberg, Josefin Segelman und 8 weitere

New England Journal of Medicine · 18.09.2025 · 393 (11) · 1051-1064

DOI: 10.1056/nejmoa2504650 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 18.09.2025. Verfasst von Anna Martling und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm. Hauptthemen laut MEDLINE: Aspirin, Class I Phosphatidylinositol 3-Kinases, Phosphatidylinositol 3-Kinases, Colonic Neoplasms. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Vetenskapsrådet, Cancerfonden, ALF grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinClass I Phosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinasesColonic NeoplasmsRectal NeoplasmsBiomarkers, TumorAdultAgedFemaleHumansMaleMiddle AgedDisease-Free SurvivalDouble-Blind MethodMutationNeoplasm Recurrence, LocalPTEN PhosphohydrolaseNeoplasm StagingDose-Response Relationship, DrugIncidenceClass Ia Phosphatidylinositol 3-KinaseAged, 80 and over

Substanzen

AspirinClass I Phosphatidylinositol 3-KinasesPhosphatidylinositol 3-KinasesPIK3CA protein, humanPTEN PhosphohydrolasePTEN protein, humanBiomarkers, TumorPIK3R1 protein, humanClass Ia Phosphatidylinositol 3-Kinase

Autor:innen und Institutionen

  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm.
  • Theme Cancer, Department of Pelvic Cancer, Karolinska University Hospital, Stockholm.
  • Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm.
  • Institute of Clinical Sciences, Lund University and Skane University Hospital Cancer Center, Lund, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
  • Department of Gastrointestinal Surgery, Akershus University Hospital, Oslo.

ORCID-Profile: Anna Martling, Eva Angenete, Rebecka Bergström

Förderung

  • Vetenskapsrådet
  • Cancerfonden
  • ALF grant
  • Cancer Research Funds of Radiumhemmet
  • Privat Donation Family B Lehander
  • Danish Comprehensive Cancer Center
  • Swedish Research Council
  • Privat Donation Family B Carlson

Zitieren

APA

Martling, A., Hed Myrberg, I., Nilbert, M., Grönberg, H., Granath, F., Eklund, M., Öresland, T., Iversen, L. H., Haapamäki, C., Janson, M., Westberg, K., Segelman, J., Ersson, U., Prytz, M., Angenete, E., Bergström, R., Mayrhofer, M., Glimelius, B., Lindberg, J., & ALASCCA Study Group (2025). Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer. New England Journal of Medicine, 393(11), 1051-1064. https://doi.org/10.1056/nejmoa2504650

Vancouver

Martling A, Hed Myrberg I, Nilbert M, Grönberg H, Granath F, Eklund M, et al. Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer. New England Journal of Medicine. 2025;393(11):1051-1064. doi:10.1056/nejmoa2504650

BibTeX
@article{Martling2025,
  author = {Martling, Anna and Hed Myrberg, Ida and Nilbert, Mef and Grönberg, Henrik and Granath, Fredrik and Eklund, Martin and Öresland, Tom and Iversen, Lene H and Haapamäki, Carola and Janson, Martin and Westberg, Karin and Segelman, Josefin and Ersson, Urban and Prytz, Mattias and Angenete, Eva and Bergström, Rebecka and Mayrhofer, Markus and Glimelius, Bengt and Lindberg, Johan and ALASCCA Study Group, ALASCCA Study Group},
  title = {Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {11},
  pages = {1051--1064},
  doi = {10.1056/nejmoa2504650}
}
Kostenlos starten →